Trial intelligence / Profile preview

Furosemide and Creatinine Tubular Stress Test in CKD

NCT05105009Phase 1Completed

Sponsor
Instituto Nacional de Cardiología Ignacio Chávez
Start
Mar 2020
Primary completion
Oct 2023
Countries
1
01

Overview

Phase 1, open-label, single-arm trial, sponsored by Instituto Nacional de Cardiología Ignacio Chávez. Primary endpoint: Tubular Residual Kidney Function at 1 year. Started Mar 2020; status: completed.

Beyond the preview

Go deeper on NCT05105009.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05105009.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call